Status:
COMPLETED
Polycystic Ovary Syndrome and BETATROPHIN
Lead Sponsor:
Hatice Akkaya
Conditions:
Polycystic Ovary
Obesity
Eligibility:
FEMALE
18-40 years
Brief Summary
This is an original study giving an information about the association body mass index, polycystic ovary syndrome and betatrophin.
Detailed Description
Introduction: Betatrophin is a protein hormone which has a significant role in glucose homeostasis and lipid metabolism. The aim of this study is to compare the levels of serum betatrophin in overweig...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Polycystic ovary syndrome according to 2003 Rotterdam PCOS Consensus diagnostic criteria
- Exclusion criteria
- pregnancy,
- an additional systemic disease (i.e.,hyperprolactinemia, thyroid dysfunction, liver or kidney diseases, cardiovascular disease, hyperlipidemia, type 1 or type 2 diabetes, chronic or acute infection within the previous 30 days),
- morbid obesity,
- smoking,
- the use of medications for contraception, androgen excess, hypertension, hyperglycemia or dyslipidemia at least 3 months before the study.
Exclusion
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT04448730
Start Date
January 1 2018
End Date
December 30 2019
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kayseri Doğumevi
Kocasinan, Kayseri, Turkey (Türkiye), 38090